The present invention relates to detomidine hydrochloride monohydrate, a method for the production of the same and to the use of the same as a medicament, that is for use as anesthetic, analgesic, muscle relaxant, sedative and any other condition susceptible to treatment with an alpha2-adrenoreceptor agonist in a mammal.
Detomidine hydrochloride monohydrate described herein represents the pure monohydrate form which additionally shows a high purity reflected the very low content of impurities and especially residual solvents. Correspondingly, detomidine hydrochloride monohydrate described herein, shows a very high storage stability which is useful for the production of pharmaceutical compositions for the treatment of pathological conditions.
申请人:University of North Texas Health Science Center at Fort Worth
公开号:US10766866B2
公开(公告)日:2020-09-08
The present invention related to compounds, compositions, methods of use, and processes for preparing compound which are useful as deterrents for terrestrial arthropods and marine organisms.
[EN] PURIFIED CRYSTALLINE DETOMIDINE HYDROCHLORIDE MONOHYDRATE, ANHYDRATE AND FREE BASE WITH LOW AMOUNTS OF ISO-DETOMIDINE AND OTHER IMPURITIES BY RECRYSTALLISATION IN WATER<br/>[FR] CHLORHYDRATE DE DÉTOMIDINE MONOHYDRATÉ SOUS FORME CRISTALLINE PURIFIÉE, ANHYDRATE DE DÉTOMIDINE ET BASE LIBRE DE DÉTOMIDINE PRÉSENTANT DE FAIBLES QUANTITÉS D'ISO-DÉTOMIDINE ET D'AUTRES IMPURETÉS, OBTENUS PAR RECRISTALLISATION DANS L'EAU